Faruqi & Faruqi, LLP Announces Investigation Of Jiangbo Pharmaceuticals, Inc.

Faruqi & Faruqi, LLP, a national law firm concentrating on investor rights, consumer rights and enforcement of federal antitrust laws, is investigating potential wrongdoing at Jiangbo Pharmaceuticals, Inc. (“JGBO” or the “Company”) (NASDAQ: JGBO). Faruqi & Faruqi, LLP seeks to determine whether JGBO and certain of its officers violated the federal securities laws by making false and misleading statements to the Company’s shareholders.

Request more information now by clicking here: www.faruqilaw.com/JGBO

Specifically, the investigation concerns: (1) the Company’s receipt of a subpoena from the U.S. Securities and Exchange Commission on March 26, 2011; (2) the resignation of Audit Committee members Michael Marks and John Wang in response to the Company’s stonewalling of the investigation that resulted from the subpoena; and (3) the sufficiency of the Company’s internal controls and financial statements.

Take Action

If you own JGBO securities or if you purchased JGBO securities and you would like to discuss your legal rights, visit www.faruqilaw.com/JGBO. You can also contact us by calling Anthony Vozzolo toll free at 877-247-4292 or at 212-983-9330 or by sending an email to [e-mail]. Faruqi & Faruqi, LLP also encourages anyone with information regarding JGBO’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP is a national law firm, representing investors, consumers and companies in the prosecution of claims under state corporate and consumer laws and the federal securities and antitrust laws. The firm is focused on providing exemplary legal services in complex litigation. Founded in 1995, the firm maintains its principal office in New York City, with offices in Delaware, California, Florida and Pennsylvania. The lawyers at Faruqi & Faruqi, LLP have demonstrated a clear commitment to championing the rights of shareholders and consumers nationwide.